RANKINGS

POPULAR STOCKS

Samsung Biologics Co.,Ltd.

KSE:207940.KS

Location

South Korea

Market Cap

USD 52.58 B

Share Price

USD 738.76

Avg Daily Volume

76,833

Change (1 day)

0.66%

Change (1 year)

41.73%

Change (YTD)

15.16%

Samsung Biologics Co.,Ltd. Total Liabilities for the year ending December 31, 2024: USD 4.33 B

Samsung Biologics Co.,Ltd. Total Liabilities is USD 4.33 B for the year ending December 31, 2024, a -9.33% change year over year. Total liabilities are the total amount of a company's debts and other obligations.
  • Samsung Biologics Co.,Ltd. Total Liabilities for the year ending December 31, 2023 was USD 4.77 B, a -20.47% change year over year.
  • Samsung Biologics Co.,Ltd. Total Liabilities for the year ending December 31, 2022 was USD 6.00 B, a 140.72% change year over year.
  • Samsung Biologics Co.,Ltd. Total Liabilities for the year ending December 31, 2021 was USD 2.49 B, a 48.79% change year over year.
  • Samsung Biologics Co.,Ltd. Total Liabilities for the year ending December 31, 2020 was USD 1.68 B, a 24.84% change year over year.
Key data
Date Total Liabilities Shareholders' Equity Cash and Short-Term Investments Receivables
Market news
KSE: 207940.KS

Samsung Biologics Co.,Ltd.

CEO Mr. John Chongbo Rim
IPO Date Nov. 11, 2016
Location South Korea
Headquarters 300, Songdo Bio-daero
Employees 4,770
Sector 🏥 Health Care
Industries
Biotechnology
🔬 Clinical Trials
💳 Credit Cards & Payments
🏥 Hospitals & Clinics
💰 Venture Capital
Description

Samsung Biologics Co.,Ltd. engages in the contract manufacturing organization (CMO) business for biopharmaceuticals products. The company operates in two segments, CMO and Contract Development Organization (CDO). It is involved in the provision of CDO services, including cell line development, upstream and downstream processes, and analytical methods and formulations. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the development and commercialization of biosimilar drugs; and manufactures mammalian cell-based antibody drugs. The company was founded in 2011 and is headquartered in Incheon, South Korea.

Similar companies

MRK

Merck & Co., Inc.

USD 79.67

-0.81%

SHL.DE

Siemens Healthineers AG

USD 54.76

0.58%

BIM.PA

bioMérieux S.A.

USD 139.32

-0.41%

BAX

Baxter International Inc.

USD 30.61

0.07%

RGC

Regencell Bioscience Holdings Limited

USD 21.73

-5.32%

2196.HK

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

USD 2.07

-0.24%

CTEC.L

ConvaTec Group Plc

USD 3.96

0.77%

GMED

Globus Medical, Inc.

USD 58.19

-0.80%

002653.SZ

Haisco Pharmaceutical Group Co., Ltd.

USD 5.93

-1.27%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 8.00

0.06%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.54

-5.44%

688617.SS

APT Medical Inc.

USD 41.26

1.54%

600161.SS

Beijing Tiantan Biological Products Co., Ltd.

USD 2.69

0.37%

TMDX

TransMedics Group, Inc.

USD 128.58

-3.06%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 3.93

1.22%

000739.SZ

Apeloa Pharmaceutical Co.,Ltd

USD 1.95

-0.78%

JUBLPHARMA.NS

Jubilant Pharmova Limited

USD 13.94

1.28%

0853.HK

MicroPort Scientific Corporation

USD 1.09

1.19%

600420.SS

Shanghai Shyndec Pharmaceutical Co., Ltd.

USD 1.49

0.31%

QDEL

QuidelOrtho Corporation

USD 28.11

-1.95%

NVCR

NovoCure Limited

USD 17.32

1.91%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 3.99

0.81%

603567.SS

Heilongjiang ZBD Pharmaceutical Co., Ltd.

USD 1.68

0.72%

300026.SZ

Tianjin Chase Sun Pharmaceutical Co.,Ltd

USD 0.52

-0.59%

688016.SS

Shanghai MicroPort Endovascular MedTech Co., Ltd.

USD 12.29

-0.52%

ABBV

AbbVie Inc.

USD 185.39

-0.09%

NOVO-B.CO

Novo Nordisk A/S

USD 67.81

-3.56%

RO.SW

Roche Holding AG

USD 341.12

-1.04%

ABT

Abbott Laboratories

USD 137.40

-0.49%

NOVN.SW

Novartis AG

USD 117.76

-0.47%

AZN.L

AstraZeneca PLC

USD 140.14

-0.36%

BSX

Boston Scientific Corporation

USD 104.29

0.16%

TMO

Thermo Fisher Scientific Inc.

USD 410.65

1.55%

AMGN

Amgen Inc.

USD 280.35

1.03%

PFE

Pfizer Inc.

USD 24.26

-0.21%

GILD

Gilead Sciences, Inc.

USD 105.93

-1.19%

SAN.PA

Sanofi

USD 95.90

-1.25%

VRTX

Vertex Pharmaceuticals Incorporated

USD 445.82

-0.99%

BMY

Bristol-Myers Squibb Company

USD 46.68

-0.74%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 52.21

0.11%

GSK.L

GSK plc

USD 19.07

-0.64%

CSL.AX

CSL Limited

USD 157.08

1.15%

COR

Cencora, Inc.

USD 292.32

-0.61%

REGN

Regeneron Pharmaceuticals, Inc.

USD 520.29

-0.38%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 128.65

-0.79%

BDX

Becton, Dickinson and Company

USD 170.90

-0.39%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.29

-1.15%

4502.T

Takeda Pharmaceutical Company Limited

USD 30.06

0.25%

ALNY

Alnylam Pharmaceuticals, Inc.

USD 321.94

-0.94%

UCB.BR

UCB SA

USD 196.91

2.58%

StockViz Staff

June 26, 2025

Any question? Send us an email